Hsg-Mlf1ip Axis As Potential Targets For Lung Adenocarcinoma Treatment.

Yuqing Lou,Rong Li,Jielin Liu,Yanwei Zhang,Wei Zhang,Xueyan Zhang,Bo Jin,Ya Liu,Zuoguang Wang,Hua Zhong,Shaojun Wen,Baohui Han
DOI: https://doi.org/10.1200/jco.2015.33.15_suppl.e13591
IF: 45.3
2015-01-01
Journal of Clinical Oncology
Abstract:e13591 Background: Hyperplasia suppressor gene (HSG) encodes a mitochondrial protein associated with mitochondrial fusion process. HSG was initially identified as a hypertension-associated gene and then implicated in the pathogenesis of variant types of cancer. However, the involvement of HSG in lung adenocarcinoma and underlying mechanisms remain elusive. Methods: HSG protein level in 30 pair lung adenocarcinoma/adjacent normal lung samples was examined with immunohistochemistry staining. Then HSG was knockdown in human lung adenocarcinoma cell line A549 with lentiviral siRNA and the impact of this on cell proliferation, cell cycle process and invasion was determined. Gene expression changes in A549 cells treated with HSG siRNA were further explored with microarray. High Content Screening was performed to determine the downstream factors involved in HSG-associated lung adenocarcinoma progress. The expression of downstream factors were then further determined in 15 lung adenocarcinoma samples by real-time...
What problem does this paper attempt to address?